Thirty-day readmission after percutaneous coronary intervention with drug eluting stent in patients with active malignancy.

e18601Background: Reducing the 30-day readmission is one of the quality performance measures upon which hospitals are being evaluated. Readmissions represent a significant economic burden to the pa...